Novel use of T22 Peptide to Block CXCR4-Mediated Cancer Metastasis
Technology
E-219-2002
Patent ID
E-219-2002-0-US-01
Country
US
Application Type
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
60/425,472
IC
NCI
Date Filed
Date Issued
Patent PDF